A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial - ScienceDirect
AHA 2020: Rivaroxaban comparable to warfarin for patients with atrial fibrillation and prosthetic valves - Cardiovascular News
Rivaroxaban noninferior to warfarin in patients with AF, bioprosthetic mitral valve: RIVER
PLOS ONE: Adherence to rivaroxaban versus apixaban among patients with non-valvular atrial fibrillation: Analysis of overall population and subgroups of prior oral anticoagulant users
Surgery | Thrombosis Adviser
Apixaban Versus Warfarin for Mechanical Heart Valve Thromboprophylaxis in a Swine Aortic Heterotopic Valve Model | Arteriosclerosis, Thrombosis, and Vascular Biology
VisualAbstract: Rivaroxaban noninferior to warfarin in patients with atrial fibrillation and bioprosthetic mitral valves | 2 Minute Medicine
Comparing Direct Oral Anticoagulants and Warfarin for Atrial Fibrillation, Venous Thromboembolism, and Mechanical Heart Valves. | Semantic Scholar
Antiplatelet and anticoagulation regimen in patients with mechanical valve undergoing PCI – State-of-the-art review - International Journal of Cardiology
Apixaban Versus Warfarin for Mechanical Heart Valve Thromboprophylaxis in a Swine Aortic Heterotopic Valve Model | Arteriosclerosis, Thrombosis, and Vascular Biology
Valvular heart disease subanalyses of direct oral anticoagulant atrial... | Download Table
RIVER Trial Presented at #AHA20 / Twitter
Rivaroxaban Versus Warfarin in Patients with Mechanical Heart Valves: Open-Label, Proof-of-Concept trial—The RIWA study | SpringerLink
![PDF] Rivaroxaban versus Warfarin in Patients with Mechanical Heart Valve: Rationale and Design of the RIWA Study | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b848b4c36977bfee20ba4b3ed5bd220554206359/3-Figure1-1.png "PDF] Rivaroxaban versus Warfarin in Patients with Mechanical Heart Valve: Rationale and Design of the RIWA Study | Semantic Scholar")
PDF] Rivaroxaban versus Warfarin in Patients with Mechanical Heart Valve: Rationale and Design of the RIWA Study | Semantic Scholar
Characteristics of the optimal candidate for mechanical heart valve... | Download Scientific Diagram
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve | NEJM
2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation - Chao - 2021 - Journal of Arrhythmia - Wiley Online Library
Usefulness and Safety of Rivaroxaban in Patients Following Isolated Mitral Valve Replacement With a Mechanical Prosthesis - American Journal of Cardiology
Usefulness and Safety of Rivaroxaban in Patients Following Isolated Mitral Valve Replacement With a Mechanical Prosthesis - American Journal of Cardiology
Rivaroxaban and Dabigatran for Suppression of Mechanical Heart Valve–Induced Thrombin Generation - The Annals of Thoracic Surgery
RIVER Trial Presented at #AHA20 / Twitter
Effectiveness and Safety of Off-label Dosing of Non–vitamin K Antagonist Anticoagulant for Atrial Fibrillation in Asian Patients | Scientific Reports
Rivaroxaban and Dabigatran for Suppression of Mechanical Heart Valve–Induced Thrombin Generation - The Annals of Thoracic Surgery
Rivaroxaban and Dabigatran for Suppression of Mechanical Heart Valve–Induced Thrombin Generation - The Annals of Thoracic Surgery
References in Bleeding Complications After Use of Novel Oral Anticoagulants in Patients Undergoing Cardiac Surgery - The Annals of Thoracic Surgery
